title: Safety evaluation of donors for living-donor liver transplantation in Chinese mainland: a single-center report.
abstract: OBJECTIVE
  To discuss the safety of donors during living donor liver transplantation (LDLT) and the authors' experience with 50 cases.
  
  
  METHODS
  Between January 1995 and March 2006, 50 patients with end-stage liver disease received LDLT in our department. Donors (at the age of 27-58 years) were healthy and antibody (ABO)-compatible. The protocol of evaluation and selection of donors, choice of surgical methods and strategy applied in the safety evaluation of donors were analyzed.
  
  
  RESULTS
  A total of 115 candidate donors were evaluated for LDLT at our center. Of these, 50 underwent successful hepatectomy for living donation. The elimination rate for donors was 43.5%. Positive hepatitis serology and ABO incompatibility were the main factors for excluding candidates. All donors recovered uneventfully. The follow-up time ranged from 3 to 135 mo. The incidence of major and minor medical complications was 12.0% and 28.0%, respectively.
  
  
  CONCLUSIONS
  LDLT provides an excellent approach to the problem of donor shortage in China. With a thorough and complete preoperative workup and meticulous intra- and postoperative management, LDLT can be performed with minimal donor morbidity.
authors: Liver Transplantation Center, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu Province, China. liguoqiang@medmail.com.cn
authors: Guo-Qiang
authors: GQ
authors: Li
authors: Feng
authors: F
authors: Zhang
authors: Xiang-Cheng
authors: XC
authors: Li
authors: Bei-Cheng
authors: BC
authors: Sun
authors: Feng
authors: F
authors: Cheng
authors: Wen-Gang
authors: WG
authors: Ge
authors: Xue-Hao
authors: XH
authors: Wang
mesh_terms: D000328:Adult; D002681:China; D005260:Female; D006801:Humans; D008107:Liver Diseases / Q000601:surgery*; D016031:Liver Transplantation / Q000009:adverse effects / Q000379:methods*; D019520:Living Donors; D008297:Male; D008875:Middle Aged; D018579:Patient Selection; D011787:Quality of Health Care; D015996:Survival Rate; D016896:Treatment Outcome
references: Transplantation. 1993 Apr;55(4):835-40
references: 7682738
references: Transplantation. 2002 Mar 15;73(5):765-9
references: 11907425
references: Transplant Proc. 2003 Nov;35(7):2533-8
references: 14612004
references: Transplantation. 2000 Jun 15;69(11):2410-5
references: 10868650
references: Ann Surg. 1991 Oct;214(4):428-37; discussion 437-9
references: 1953097
references: Lancet. 1989 Aug 26;2(8661):497
references: 2570198
references: JAMA. 2003 Jul 9;290(2):181-2
references: 12851257
references: Arch Surg. 2000 Mar;135(3):336-40
references: 10722038
references: Clin Transplant. 1995 Feb;9(1):31-4
references: 7742580
references: N Engl J Med. 2002 Apr 4;346(14):1038
references: 11932469
references: Transplant Proc. 2004 Oct;36(8):2224-5
references: 15561198
references: Ann Surg. 1990 Sep;212(3):368-75; discussion 375-7
references: 2396888
references: Clin Transplant. 2003 Aug;17(4):308-24
references: 12868987
references: N Engl J Med. 1990 May 24;322(21):1505-7
references: 2336076
references: Eur Rev Med Pharmacol Sci. 2005 Sep-Oct;9(5):295-7
references: 16231593
references: Ann Surg. 2003 Jul;238(1):137-48
references: 12832976
references: Clin Liver Dis. 2003 Aug;7(3):651-65, viii
references: 14509532
references: Arch Surg. 2001 Apr;136(4):425-33
references: 11296114
references: Hepatology. 1997 Nov;26(5):1176-81
references: 9362359
references: Transplantation. 2003 Feb 15;75(3 Suppl):S16-9
references: 12589132
references: J Hepatobiliary Pancreat Surg. 2003;10(1):31-44
references: 12827475